FDA Adverse Event Injury Summary report: N

PROMUS PREMIER SELECT

MDR report key: 9695369 · Received February 11, 2020

Report

Report Number
2134265-2020-00813
Event Type
Injury
Date Received
February 11, 2020
Date of Event
January 13, 2020
Report Date
February 11, 2020
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NIQ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT.

Description of Event or Problem · 1

IT WAS REPORTED THAT A DISSECTION OCCURRED. A PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY WAS PERFORMED ON DE NOVO TARGET LESION LOCATED IN THE LEFT CIRCUMFLEX (LCX). A 32 X 3.00 PROMUS PREMIER SELECT STENT WAS DEPLOYED IN THE LCX. AN ORTHOGONAL VIEW WAS TAKEN TO VIEW THE DEPLOYED STENT AND NOTED AN EDGE DISSECTION. TO COVER THE EDGE DISSECTION, ANOTHER STENT WAS DEPLOYED. THE PROCEDURE WAS COMPLETED AND THE PATIENT WAS REPORTED TO BE STABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
156335 PROMUS PREMIER SELECT STENT, CORONARY, DRUG-ELUTING NIQ BOSTON SCIENTIFIC CORPORATION 10667 0024217450

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention